Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-30
DOI
10.1038/s41467-020-17526-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimizing panel-based tumor mutational burden (TMB) measurement
- (2019) J Budczies et al. ANNALS OF ONCOLOGY
- Lack of detectable neoantigen depletion signals in the untreated cancer genome
- (2019) Jimmy Van den Eynden et al. NATURE GENETICS
- The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
- (2019) Rik G. H. Lindeboom et al. NATURE GENETICS
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- A pan-cancer genome-wide analysis reveals tumour dependencies by induction of nonsense-mediated decay
- (2017) Zhiyuan Hu et al. Nature Communications
- Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
- (2017) Alexandra Snyder et al. PLOS MEDICINE
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Translational plasticity facilitates the accumulation of nonsense genetic variants in the human population
- (2016) Sujatha Jagannathan et al. GENOME RESEARCH
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- The rules and impact of nonsense-mediated mRNA decay in human cancers
- (2016) Rik G H Lindeboom et al. NATURE GENETICS
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- (2015) Massimo Andreatta et al. BIOINFORMATICS
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
- (2015) Sachet A Shukla et al. NATURE BIOTECHNOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Frameshift mutations, neoantigens and tumor-specific CD8+T cells in microsatellite unstable colorectal cancers
- (2015) Pauline Maby et al. OncoImmunology
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation
- (2011) S. Apcher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma
- (2010) Osama E Rahma et al. Journal of Translational Medicine
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started